INTRACEREBRAL TUMOR-ASSOCIATED HEMORRHAGE CAUSED BY OVEREXPRESSION OFTHE VASCULAR ENDOTHELIAL GROWTH-FACTOR ISOFORMS VEGF(121) AND VEGF(165) BUT NOT VEGF(189)
Sy. Cheng et al., INTRACEREBRAL TUMOR-ASSOCIATED HEMORRHAGE CAUSED BY OVEREXPRESSION OFTHE VASCULAR ENDOTHELIAL GROWTH-FACTOR ISOFORMS VEGF(121) AND VEGF(165) BUT NOT VEGF(189), Proceedings of the National Academy of Sciences of the United Statesof America, 94(22), 1997, pp. 12081-12087
The vascular endothelial growth factor (VEGF) has been shown to be a s
ignificant mediator of angiogenesis during a variety of normal and pat
hological processes, including tumor development, Human U87MG glioblas
toma cells express the three VEGF isoforms: VEGF(121), VEGF(165), and
VEGF(189), Here, we have investigated whether these three isoforms hav
e distinct roles in glioblastoma angiogenesis. Clones that overexpress
ed each isoform were derived and inoculated into mouse brains, Mice th
at received VEGF(121)- and VEGF(165)-overexpressing cells developed in
tracerebral hemorrhages after 60-90 hr, In contrast, mice implanted wi
th VEGF(189)-overexpressing cells had only slightly larger tumors than
those caused by parental cells and little evidence of hemorrhage at t
hese early times after implantation, whereas, after longer periods of
growth, enhanced angiogenicity and tumorigenicity were apparent, There
was rapid blood vessel growth and breakdown around the tumors caused
by cells overexpressing VEGF(121) and VEGF(165), whereas there was sim
ilar vascularization but no eruption in the vicinity of those tumors c
aused by cells overexpressing VEGF(189), and none on the border of the
tumors caused by the parental cells, Thus, by introducing VEGF-overex
pressing glioblastoma cells into the brain, we have established a repr
oducible and predictable ill vivo model of tumor-associated intracereb
ral hemorrhage caused by the enhanced expression of single molecular s
pecies, Such a model should be useful for uncovering the role of VEGF
isoforms in the mechanisms of angiogenesis and for investigating intra
cerebral hemorrhage due to ischemic stroke or congenital malformations
.